Pharmaceutical decisions depend on analytical methods that produce valid data on a product's safety, identity, strength, purity and quality. This 90-minute analytical method validation and transfer course reviews the regulatory guidance and shows how to validate and transfer QC test methods.
FDA, ICH and USP have all expanded validation requirements, yet guidance on how to comply is limited. You'll cover terminology, the validation lifecycle, pre-validation work such as the analytical target profile, and each validation characteristic, from specificity and accuracy to LOD, LOQ and robustness.
The course also covers protocols, acceptance criteria, statistics, reports and deviations, with a focus on efficient experimental design and documentation.
WHY SHOULD YOU ATTEND?
Validation shows that a method is fit for its intended use, and regulators require the data for NDA, BLA and MAA submissions covering in-process, release and stability assays. This course gives you the knowledge and tools to plan and execute validation packages and avoid the issues reviewers and inspectors commonly find.
It suits analytical development, QA, QC, validation and regulatory affairs professionals involved in method development, validation, verification or transfer.
AREA COVERED
1. Regulatory requirements and guidance
- Review of regulatory guidelines on method validation and transfer
- Terminology: qualification, validation, revalidation and verification
- FDA, EMA and ICH requirements and guidance
- The validation lifecycle for analytical methods
2. Pre-validation (stage 1)
- Analytical target profile (ATP)
- ICH Q8, Q9 and Q10 pre-validation requirements
- QC instrument qualification
- Training
- Critical assay reagent qualification
3. Validation characteristics (stage 2)
- Specificity, accuracy, precision, linearity and range
- LOD and LOQ
- Robustness and stability-indicating methods
- The value of system suitability controls
4. Test method validation protocol
- Elements of a validation protocol
- Pre-planning and planning steps
- Identifying and documenting the assay characteristics to validate
- Why acceptance criteria must be set in advance
5. Test method validation report
- Elements of the validation report and how it links to the protocol
- Meeting the pre-defined acceptance criteria
- Handling deviations and OOS results when they happen
6. Regulatory concerns
- Validation issues found during market dossier review
- Validation issues found during inspections
- Continuous improvement of test method validation under ICH Q10
LEARNING OBJECTIVES
- Define qualification, validation, revalidation and verification
- Apply FDA, EMA and ICH guidance across the analytical method validation lifecycle
- Complete pre-validation steps, including the analytical target profile and instrument qualification
- Evaluate specificity, accuracy, precision, linearity, range, LOD, LOQ and robustness
- Write validation protocols with pre-defined acceptance criteria and suitable statistics
- Prepare validation reports and handle deviations and OOS results
- Anticipate validation issues raised in dossier reviews and inspections
WHO WILL BENEFIT?
- Analytical Development
- Quality Assurance
- Quality Control
- Validation
- Regulatory Affairs
Validation shows that a method is fit for its intended use, and regulators require the data for NDA, BLA and MAA submissions covering in-process, release and stability assays. This course gives you the knowledge and tools to plan and execute validation packages and avoid the issues reviewers and inspectors commonly find.
It suits analytical development, QA, QC, validation and regulatory affairs professionals involved in method development, validation, verification or transfer.
1. Regulatory requirements and guidance
- Review of regulatory guidelines on method validation and transfer
- Terminology: qualification, validation, revalidation and verification
- FDA, EMA and ICH requirements and guidance
- The validation lifecycle for analytical methods
2. Pre-validation (stage 1)
- Analytical target profile (ATP)
- ICH Q8, Q9 and Q10 pre-validation requirements
- QC instrument qualification
- Training
- Critical assay reagent qualification
3. Validation characteristics (stage 2)
- Specificity, accuracy, precision, linearity and range
- LOD and LOQ
- Robustness and stability-indicating methods
- The value of system suitability controls
4. Test method validation protocol
- Elements of a validation protocol
- Pre-planning and planning steps
- Identifying and documenting the assay characteristics to validate
- Why acceptance criteria must be set in advance
5. Test method validation report
- Elements of the validation report and how it links to the protocol
- Meeting the pre-defined acceptance criteria
- Handling deviations and OOS results when they happen
6. Regulatory concerns
- Validation issues found during market dossier review
- Validation issues found during inspections
- Continuous improvement of test method validation under ICH Q10
- Define qualification, validation, revalidation and verification
- Apply FDA, EMA and ICH guidance across the analytical method validation lifecycle
- Complete pre-validation steps, including the analytical target profile and instrument qualification
- Evaluate specificity, accuracy, precision, linearity, range, LOD, LOQ and robustness
- Write validation protocols with pre-defined acceptance criteria and suitable statistics
- Prepare validation reports and handle deviations and OOS results
- Anticipate validation issues raised in dossier reviews and inspections
- Analytical Development
- Quality Assurance
- Quality Control
- Validation
- Regulatory Affairs
Speaker Profile
Kelly Thomas
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Upcoming Webinars
Medical Device Cybersecurity Following FDA’s 2026 Premarket…
Managing Toxic Employees: Strategies For Leaders To Effecti…
California Meal and Rest Breaks: What You Don't Know Can Co…
Human Error Reduction Techniques for Floor Supervisors
Unlock Employee Loyalty: Stay Interviews Will Keep Them Eng…
Performance of Root Cause Analysis, CAPA, and Effectiveness…
Your AI Advantage: How HR Professionals Can Use Claude to S…
The Anti-Kickback Statute: Enforcement and Recent Updates
Empowering Conflict Resolution: Letting Go to Gain Control
Wage & Hour Laws: Ensuring Compliance with the Fair Labor S…
Using Copilot to Format Legal Documents in Microsoft Word
Dealing With Difficult People: At Work & In Life
Using Stay Interviews To Improve Employee Retention & Engag…
AI in Word - Smarter Writing and Document Creation with Cha…
FDA Current Trends in Compliance and Enforcement for FDA-Re…
Zero Acceptance Sampling to Reduce Inspection Costs
Why EBITDA Doesn't Spell Cash Flow and What Does?
Mastering Tough Conversations: Turn Conflict into Clarity, …
Enhancing Pivot Tables with Images: Visualize Your Data Lik…
Discover how Emotional Intelligence turns AI from a technic…
Understanding Financial Statements for Non-Financial Profes…
SOPs - How to Write Them to Satisfy those Inspectors
Managing Projects When AI Joins the Team: Human Judgment, A…